Hepatitis C and Kidney Transplantation

Table 2

Death rate in HCV+ve versus HCV−ve patients after Kidney Transplantation.

	Year of publication	Followup after KT in months (mean)*	HCV-positive Death	HCV-negative Death	𝑃-value
Pereira et al. [23]	1995	68/70	11/29 (38%)	26/72 (36%)	n.s.
Pereira et al. [47]	1995	68/83	9/22 (41%)	16/78 (20.5%)	n.s.
Legendre et al. [48]	1998	79/81	15/112 (13.4%)	19/387 (5%)	.01
Gentil et al. [49]	1999	62/57	13/85 (15.3%)	11/235 (4.7%)	.003
Lee et al. [50]	2001	72	31/151 (20.5%)	46/326 (14%)	n.s.
Breitenfeldt et al. [51]	2002	110.4	38/130 (29%)	164/797 (20.6%)	.001
Einollahi et al. [44]	2003	n.a.	2/41 (5%)	34/868 (4%)	.74
Bruchfeld et al. [52]	2004	130	29/51 (57%)	170/520 (32.7%)	.001
Scott et al. [3]	2010	62.4	32/140 (23%)	743/7432 (10%)	.0001

*Data are given for anti-HCV+ve/anti-HCV−ve patients when appropriate.
n.a.: not available; n.s.: not statistically significant.